Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Vomiting × Esomeprazole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 7 Barrett Esophagus 7 Gastritis 5 Breast Neoplasms 4 Stomach Ulcer 3 Peptic Ulcer 3 Gastroesophageal Reflux 3 Dyspepsia 3 Zollinger-Ellison Syndrome 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Vomiting 1 Radiation Esophagitis 1 Precancerous Conditions 1 Peptic Ulcer Hemorrhage 1 Neoplasm Metastasis 1 Nausea 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Hot Flashes 1 Hemorrhage 1 Head and Neck Neoplasms 1 Gastrointestinal Stromal Tumors 1 Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer 1 Esophagitis, Peptic 1 Esophagitis 1 Dysbiosis 1 Colonic Neoplasms 1 Advanced Non-small Cell Lung Cancer 1

Interventions

Dexamethasone 49 Aprepitant 38 Palonosetron 33 Ondansetron 29 Granisetron 22 Calcium Dobesilate 14 fosaprepitant 13 Olanzapine 12 Therapeutics 8 dexamethasone acetate 7 ramosetron 6 casopitant 6 Tropisetron 6 Cyclophosphamide 6 netupitant, palosentron drug combination 5 dexamethasone 21-phosphate 5 Radiotherapy 5 Metoclopramide 5 Doxorubicin 5 netupitant 4 dolasetron 4 Acupressure 4 Vincristine 3 Tablets 3 Surveys and Questionnaires 3 Prochlorperazine 3 Lorazepam 3 Electroacupuncture 3 Dronabinol 3 Diphenhydramine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00206440 2018-12-06

NEXIUM

Baylor Breast Care Center

Phase 3 Terminated

43 enrolled 5 charts

Breast Neoplasms, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡